MOESM7 of Markers of MEK inhibitor resistance in low-grade serous ovarian cancer: EGFR is a potential therapeutic target
收藏数据链接：
官方服务：
资源简介：
Additional file 7: Table S5. Compusyn data from selumetinib/trametinib and erlotinib drug combinations in MEKi-re LGSC cell lines.
创建时间：
2019-01-09
